Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Seronegative”

49 trials

Showing 20 of 49 results

Very early researchStudy completedNCT04791007
What this trial is testing

OB-002H Gel Administered Vaginally and Rectally in HIV-1 Seronegative Adults

Who this might be right for
HIV Prevention
Orion Biotechnology Polska Sp. z o.o. 60
Not applicableWithdrawnNCT01059084
What this trial is testing

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

Who this might be right for
HIVHIV Infections
University of Washington
Early research (Phase 1)Study completedNCT00001053
What this trial is testing

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00000795
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Testing effectiveness (Phase 2)Study completedNCT03499795
What this trial is testing

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Who this might be right for
Anal Neoplasm
Inovio Pharmaceuticals 23
Not applicableUnknownNCT01208376
What this trial is testing

Prevalence of Liver Fibrosis and Progression of Liver Fibrosis

Who this might be right for
HIV Infection and Chronic Alanine Aminotransferase Elevation
Helen Kovari-Kramer 195
Early research (Phase 1)Study completedNCT00000845
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Post-approval studies (Phase 4)Study completedNCT00648817
What this trial is testing

Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers

Who this might be right for
HIV Infections
Gilead Sciences 8
Early research (Phase 1)Ended earlyNCT04032717
What this trial is testing

Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT)

Who this might be right for
HIV Prevention
Rhonda Brand 18
Early research (Phase 1)Study completedNCT00002232
What this trial is testing

GENEVAX-HIV, a Possible Vaccine

Who this might be right for
HIV InfectionsHIV Seronegativity
Wyeth-Lederle Vaccines
Early research (Phase 1)Study completedNCT03239483
What this trial is testing

Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT01386489
What this trial is testing

Immune Responses to Two Experimental HIV Vaccines in Healthy Adults

Who this might be right for
HIV NegativeAdaptive ImmunityInnate Immunity
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Study completedNCT02990325
What this trial is testing

A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults

Who this might be right for
HIV InfectionsHealth Volunteers
Abivax S.A. 36
Not applicableStudy completedNCT00005762
What this trial is testing

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableUnknownNCT00069485
What this trial is testing

Resistance to HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)Study completedNCT00076232
What this trial is testing

Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

Who this might be right for
HIV InfectionsHIV SeronegativityHerpes Genitalis
National Institute of Allergy and Infectious Diseases (NIAID) 3,682
Early research (Phase 1)Study completedNCT02033109
What this trial is testing

Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use

Who this might be right for
HIV
Population Council 35
Early research (Phase 1)Study completedNCT00002231
What this trial is testing

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

Who this might be right for
HIV InfectionsHIV Seronegativity
Wyeth-Lederle Vaccines
Not applicableStudy completedNCT02404805
What this trial is testing

Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers

Who this might be right for
HIVHepatitis C
University of Colorado, Denver 25
Early research (Phase 1)UnknownNCT00013572
What this trial is testing

HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
Walter Reed Army Institute of Research (WRAIR) 36
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation